Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Tekes.
Twitter and News
Development of pan-corona vaccine against novel pandemic viruses
Professor Vincenzo Cerullo held a talk at Tiedekulma 11th of June, 2020 about the development of a pan-corona vaccine
Professor Vincenzo Cerullo to lead development of vaccine for SARS-COV-2
The COVID-19 pandemic is an immediate global challenge and in the current crisis situation our focus has to be saving human lives and also...
Members of the ImmunoViroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.
One of my main priorities is promoting science to non-scientific audience and I believe that it has never been a better time then now to do...